NYU and Heffter Research Institute Overview of Psilocybin Therapy - EntheoGeneration 2019
Channel: EntheoGeneration
Date: 2019-12-06

Stephen Ross, M.D., presents an overview of current psilocybin research on addictions, mood and anxiety disorders, mystical experiences, and brain function. He also reviews the psilocybin research projects that the Heffter Research Institute is currently funding and planning: the enhancement of therapeutic neuroplasticity, as well as the treatment of addiction (alcohol, nicotine, cocaine, and opioids), depression, obsessive-compulsive disorder (OCD), headaches, anorexia, and depression in newly diagnosed Alzheimer's patients.
 
Stephen Ross, M.D., is a Professor of Psychiatry at New York University (NYU) and Co-Directs the NYU Psychedelic Research Group, where he is Principal Investigator of the NYU Psilocybin Cancer, Religious Professionals and Alcoholism Projects.
 
Hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS) and the Zendo Project, the EntheoGeneration speaker series launched at Burning Man 2019. A wide variety of educational presentations were held from Wednesday, August 28, 2019, through Saturday, August 31, 2019, featuring topics that explore the latest research and healing opportunities for humanity, how to address issues of inclusion and access, strategies to protect indigenous plant medicine traditions and more, from the brightest leaders active in the field today.
 
EntheoGeneration:
https://zendoproject.org/entheogeneration/
 
The Multidisciplinary Association for Psychedelic Studies (MAPS):
https://maps.org
 
The Zendo Project - Psychedelic Peer Support:
https://zendoproject.org